Physician

Jill E Hemmelgarn, D.O.

According to 2025 Medicare claims, Jill Hemmelgarn, D.O. (NPI: 1700221132) practices nephrology in the Lima, OH market, with the plurality of this provider's patient population coming from Allen, OH. This provider's primary affiliated billing organization is MERCY HEALTH PHYSICIANS LIMA SPECIALTY CARE LLC (NPI: 1518589803; TIN: 850900392) and primary practice location at 45805-4602. Hemmelgarn is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Hemmelgarn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 861 traditional Medicare patients, billed 3,154 HCPCS/CPT codes, and received $240,632 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,751 prescription claims across 590 beneficiaries totaling $663,731 in drug costs, led by Jynarque (Tolvaptan). DME data shows 301 claims. Open Payments data shows 9 records totaling $281. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $28,474 to $240,632. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,705 to $663,731. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$120K$241K2018 Medicare payment: $28,474 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $143,215 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $118,378 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $179,798 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $223,645 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $187,160 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $240,632 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018209475$28,474
20196902,253$143,215
20206041,761$118,378
20217072,443$179,798
20227802,658$223,645
20236812,356$187,160
20248613,154$240,632

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$332K$664K2015 Drug cost: $2,705 (USD; Tot_Drug_Cst)2016 Drug cost: $2,655 (USD; Tot_Drug_Cst)2017 Drug cost: $5,055 (USD; Tot_Drug_Cst)2018 Drug cost: $28,230 (USD; Tot_Drug_Cst)2019 Drug cost: $174,891 (USD; Tot_Drug_Cst)2020 Drug cost: $536,313 (USD; Tot_Drug_Cst)2021 Drug cost: $79,358 (USD; Tot_Drug_Cst)2022 Drug cost: $599,285 (USD; Tot_Drug_Cst)2023 Drug cost: $485,870 (USD; Tot_Drug_Cst)2024 Drug cost: $663,731 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151126$2,705
20162548$2,655
20175397$5,055
2018146361$28,230
20192271,472$174,891
20202631,578$536,313
20213402,083$79,358
20224793,297$599,285
20235013,152$485,870
20245903,751$663,731

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.1K$10K2019 Medicare payment: $358 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,893 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $6,067 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $10,202 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,226 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $7,627 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R19$358
2020N/R52$3,893
2021N/R69$6,067
2022N/R139$10,202
2023N/R183$5,226
202412301$7,627

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more109109$106
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes200257$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more494765$69
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes2821,339$59
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's95100$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JynarqueTolvaptan13364$255,912
FarxigaDapagliflozin Propanediol1156,080$107,128
VelphoroSucroferric Oxyhydroxide341,020$53,869
KerendiaFinerenone301,620$34,773
VeltassaPatiromer Calcium Sorbitex251,108$32,261

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7515Cyclosporine, oral, 25 mgNN/R20$2,440
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodN1292$1,637
J7518Mycophenolic acid, oral, 180 mgNN/R33$1,509
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R59$740
J7517Mycophenolate mofetil, oral, 250 mgNN/R34$461

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$281Ardelyx, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jill E. Hemmelgarn, D.O.?

Tedicare shows public-source Medicare data for Jill E. Hemmelgarn, D.O. (NPI 1700221132), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jill E. Hemmelgarn, D.O. have ACO affiliation data?

Jill E. Hemmelgarn, D.O. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jill E. Hemmelgarn, D.O.?

Jill E. Hemmelgarn, D.O. is linked to MERCY HEALTH PHYSICIANS LIMA SPECIALTY CARE LLC (billing NPI 1518589803) in the available physician profile data.

Does Jill E. Hemmelgarn, D.O. have Open Payments data?

Jill E. Hemmelgarn, D.O. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.